Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Melanoma

  Free Subscription


Articles published in Ann Surg

Retrieve available abstracts of 7 articles:
HTML format



Single Articles


    July 2023
  1. SCOVILLE SD, Stanek JR, Rinehardt H, Sutthatarn P, et al
    Comparison of Outcomes between Surveillance Ultrasound and Completion Lymph Node Dissection in Children and Adolescents with Sentinel Lymph Node Positive Cutaneous Melanoma.
    Ann Surg. 2023 Jul 24. doi: 10.1097/SLA.0000000000006022.
    PubMed     Abstract available


    February 2023
  2. MARIANI P, Bidard FC, Rampanou A, Houy A, et al
    Circulating tumor DNA as a Prognostic Factor in Patients with Resectable Hepatic Metastases of Uveal Melanoma.
    Ann Surg. 2023 Feb 27. doi: 10.1097/SLA.0000000000005822.
    PubMed     Abstract available


    November 2022
  3. MENEVEAU MO, Vavolizza RD, Mohammad A, Kumar P, et al
    A Step Toward Personalized Surgical Decision Making: Machine Learning Predicts One Versus Numerous Melanoma Lymph Node Metastases Using RNA-Sequencing.
    Ann Surg. 2022 Nov 25. doi: 10.1097/SLA.0000000000005761.
    PubMed     Abstract available


    July 2022
  4. MONCRIEFF MD, Bastiaannet E, Underwood B, Francken AB, et al
    Follow-up Schedule for Patients with Sentinel Node Negative Cutaneous Melanoma: an International Phase III Randomised Clinical Trial.
    Ann Surg. 2022 Jul 22. pii: 00000658-990000000-00177.
    PubMed     Abstract available


  5. RHODIN KE, Gaughan EM, Raman V, Salama AK, et al
    Multicenter Experience with Neoadjuvant Therapy in Melanoma Highlights Heterogeneity in Contemporary Practice.
    Ann Surg. 2022 Jul 7. pii: 00000658-990000000-00089.
    PubMed     Abstract available


    January 2022
  6. BROMAN KK, Hughes TM, Bredbeck BC, Sun J, et al
    International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node Positive Melanoma at Major Referral Centers.
    Ann Surg. 2022 Jan 27. pii: 00000658-900000000-93085.
    PubMed     Abstract available


    April 2021
  7. BLANKENSTEIN SA, Rohaan MW, Klop WMC, van der Hiel B, et al
    Neoadjuvant Cytoreductive Treatment with BRAF/MEK Inhibition of prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single Arm, Open-label Phase II Trial.
    Ann Surg. 2021 Apr 9. pii: 00000658-900000000-93605.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.